Pathologic characteristics of histiocytic and dendritic cell neoplasms
Author:
Open Access
- 7 May 2024
- journal article
- review article
- Published by Springer Nature in Blood Research
- Vol. 59 (1) , 1-19
Abstract
Histiocytic and dendritic cell neoplasms comprise diverse tumors originating from the mononuclear phagocytic system, which includes monocytes, macrophages, and dendritic cells. The 5th edition of the World Health Organization (WHO) classification updating the categorization of these tumors, reflecting a deeper understanding of their pathogenesis.In this updated classification system, tumors are categorized as Langerhans cell and other dendritic cell neoplasms, histiocyte/macrophage neoplasms, and plasmacytoid dendritic cell neoplasms. Follicular dendritic cell neoplasms are classified as mesenchymal dendritic cell neoplasms within the stroma-derived neoplasms of lymphoid tissues.Each subtype of histiocytic and dendritic cell neoplasms exhibits distinct morphological characteristics. They also show a characteristic immunophenotypic profile marked by various markers such as CD1a, CD207/langerin, S100, CD68, CD163, CD4, CD123, CD21, CD23, CD35, and ALK, and hematolymphoid markers such as CD45 and CD43. In situ hybridization for EBV-encoded small RNA (EBER) identifies a particular subtype. Immunoprofiling plays a critical role in determining the cell of origin and identifying the specific subtype of tumors. There are frequent genomic alterations in these neoplasms, especially in the mitogen-activated protein kinase pathway, including BRAF (notably BRAF V600E), MAP2K1, KRAS, and NRAS mutations, and ALK gene translocation.This review aims to offer a comprehensive and updated overview of histiocytic and dendritic cell neoplasms, focusing on their ontogeny, morphological aspects, immunophenotypic profiles, and molecular genetics. This comprehensive approach is essential for accurately differentiating and classifying neoplasms according to the updated WHO classification.Keywords
Funding Information
- National Research Foundation of Korea Grant funded by the Korean Government (No. NRF-2019R1A2C1002370)
This publication has 80 references indexed in Scilit:
- Fibroblastic reticular cells provide a supportive niche for lymph node–resident macrophagesEuropean Journal of Immunology, 2023
- Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell SarcomaThe Oncologist, 2021
- Origins and diversity of macrophages in health and diseaseClinical & Translational Immunology, 2020
- Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literatureAnnals of Diagnostic Pathology, 2018
- CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesionsCancer, 2018
- Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcomaAnnals of Diagnostic Pathology, 2015
- Homeostasis in the mononuclear phagocyte systemTrends in Immunology, 2014
- Follicular dendritic cells: origin, phenotype, and function in health and diseaseTrends in Immunology, 2014
- Follicular Dendritic Cells Emerge from Ubiquitous Perivascular PrecursorsCell, 2012
- Transcription Factor E2-2 Is an Essential and Specific Regulator of Plasmacytoid Dendritic Cell DevelopmentCell, 2008